Wall Street is seeing green.

Analysts at Cowen note the U.S. cannabis market could rocket to $16 billion by 2025.  

Analysts at Piper Jaffray believe we could be looking at a global market value of between $250 billion to $500 billion a year.  “We believe the long-term growth can be significant — both from transitioning illicit trade to legal sales, medical sales, and from transitioning sales in health (and) wellness categories to CBD-infused products,” said the analysts, as quoted by MarketWatch. 

As the boom just begins, three of the best cannabis stocks to own include the following:

Canopy Growth Corporation CGC

After receiving a $4 billion investment from Constellation Brands, the stock continues to show promise.  For example, it’s making an investment of $100 million and $150 million to create a large-scale hemp production facility in New York over the next 100 days. It’s currently looking at sites in the Southern Tier of the state, notes Bloomberg.  

In addition, the company just teamed up with Martha Stewart to produce a line of CBD products for people and their pets.  'I am delighted to establish this partnership with Canopy Growth and share with them the knowledge I have gained after years of experience in the subject of living,' Stewart said, as quoted by CNN.

Tilray Inc. TLRY

Tilray is making major headlines after jumping into the U.S. CBD market.  That’s after agreeing to acquire Manitoba Harvest for $317 million in cash and stock.  

Manitoba Harvest CEO Bill Chiasson said the “current plan is to introduce a line of CBD-infused tinctures, a CBD spray and CBD gel caps,” as quoted by MarketWatch.  ““We have retailers who have expressed a lot of interest in that, in states where it’s more friendly.”

CannTrust Holdings CTST 

Over the last few weeks, the company applied to list its shares on the NYSE.  'CannTrust has firmly established itself as one of the top licensed producers in Canada with a global platform rooted in trust, science and innovation,' CannTrust CEO Peter Aceto said. 'A listing on the NYSE is a natural step forward in our evolution as we look to broaden our investor base, increase the company's exposure and expand our business on an international scale.'

Better yet, the company is targeting 100,000 kilograms of annual production capacity.  Should it deliver on that target, it would be among the biggest Canadian marijuana stocks. Plus, thanks in large part to growing acceptance of cannabis -- including Canada's legalization in October 2018, further U.S. state approval, and growing interest from corporate America the global market is expected to reach $146.4 billion by 2025, according to Grand View Research Inc. from $7.06 billion in 2016.